Obviously, sgCas9‐AdV/Gel injection elevated the levels of CD3+CD4+ (helper) and CD3+CD8+ (cytotoxic) T cells in tumor tissues (Figure 4A,B and Figure S14, Supporting Information), while reducing the infiltration of Tregs (Figure 4C and Figure S15, Supporting Information). This evidence concerns the gene CD8A and neoplasm.